^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    KU70/KU80 inhibitor

    Related drugs:
    9ms
    A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors (clinicaltrials.gov)
    P1/2, N=165, Recruiting, Valerio Therapeutics
    New P1/2 trial
    |
    VIO-01